Walleye Capital LLC Karuna Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $193,212 - $381,420	-1,200 Reduced 40.0%	1,800 $569,000
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $32,932 - $43,616	-200 Reduced 6.25%	3,000 $507,000
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $52,896 - $72,066	-300 Reduced 8.57%	3,200 $693,000
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $387,192 - $490,464	-2,400 Reduced 40.68%	3,500 $635,000
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $383,060 - $473,640	-2,000 Reduced 25.32%	5,900 $1.16 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $977,941 - $2.19 Million	7,900 New	7,900 $1.78 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.